Insider tradingForm 4
Cue Biopharma, Inc. (CUE) Insider Trading
7 open-market trades reported since Aug 14, 2026: 0 purchases worth $0 and 7 sales worth $2.43M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Shao-Lee Lin | CEO | 0 | $0 | 3 | $1.91M |
| Sumita Ray | General Counsel | 0 | $0 | 2 | $317K |
| Michael Vincent Meluzio | VP | 0 | $0 | 2 | $201K |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 14 | Shao-Lee LinCEO | ▼ SELL | $305K | |
| Oct 14 | Sumita RayGeneral Counsel | ▼ SELL | $52K | |
| Oct 14 | Michael Vincent MeluzioVP | ▼ SELL | $32K | |
| Aug 17 | Sumita RayGeneral Counsel | ▼ SELL | $266K | |
| Aug 17 | Michael Vincent MeluzioVP | ▼ SELL | $169K | |
| Aug 14 | Shao-Lee LinCEO | ▼ SELL | $1.08M | |
| Aug 14 | Shao-Lee LinCEO | ▼ SELL | $523K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings